Whole-body periodic acceleration reduces brain damage in a focal ischemia model |
| |
Authors: | R. Martí nez-Murillo,J. Serrano,A.P. Ferná ndez,A. Martí nez |
| |
Affiliation: | 1. Department of Cellular, Molecular, and Developmental Neurobiology, Instituto Cajal, Consejo Superior de Investigaciones Científicas, Avda. Doctor Arce 37, 28002, Madrid, Spain;2. Angiogenesis Study Group, Center for Biomedical Research of La Rioja, C/Piqueras 98, 26006 Logroño, Spain |
| |
Abstract: | Stroke is the second most common cause of death and major cause of disability worldwide. Actual treatment involves surgery and/or thrombolytic drugs, but there is an urgent need for new approaches. Periodic acceleration, a rocking headward to footward movement of the whole body, is a non-invasive method to induce pulsatile shear stress on the vascular endothelium eliciting an enhanced production and secretion of endothelium-derived products such as nitric oxide, prostacyclin, prostaglandin E2, tissue plasminogen activator (tPA), and adrenomedullin. All these products have been shown to protect the brain from ischemic injuries. A rat model of focal brain ischemia was treated with application of periodic acceleration for 3 h immediately after the onset of ischemia. Controls remained static for the same period of time. Brain damage was assessed by magnetic resonance imaging (MRI) and biochemical markers. A significant reduction in brain damage was observed, 7 days post-ischemia, in rocked rats when compared with the static controls, through MRI. Furthermore, rocked animals had significantly lower levels of Beclin 1 and fractin than their static counterparts, and some isoforms of nitric oxide synthase were regulated by periodic acceleration. Our results show that periodic acceleration may provide a novel, affordable, non-invasive therapeutic option for the treatment of stroke. |
| |
Keywords: | stroke endothelium-derived products apoptosis brain damage MRI |
本文献已被 ScienceDirect 等数据库收录! |
|